Memorial Sloan Kettering and Hackensack Meridian Health have joined forces to take a bold step toward changing the face of cancer care in New Jersey — and, potentially, for patients everywhere.
The partnership between one of the world’s most respected comprehensive centers devoted exclusively to cancer and one of New Jersey’s largest healthcare systems is unprecedented in cancer care.
Currently, MSK and Hackensack Meridian treat one in five New Jersey residents who are diagnosed with cancer. Combined, the two organizations annually will serve the most patients with cancer in the region, and many of their shared programs will be among the largest in the country.
One of the main goals of the partnership is to bring both MSK’s and Hackensack Meridian’s portfolios of hundreds of clinical trials to more patients, increasing the ability to find new treatments for cancer, faster.
The partnership will develop joint standards of care through the oversight of a governing board composed of members from both MSK and Hackensack Meridian. These guidelines will apply to all partnership sites in New Jersey, which includes MSK’s locations in Basking Ridge, Monmouth County, and Bergen County as well as Hackensack’s John Theurer Cancer Center, in Hackensack. Doctors employed by MSK and Hackensack Meridian will continue to care for patients at their respective sites, and each institution will continue to independently own, operate, and manage their existing New Jersey sites. A joint entity will be created to own and operate any newly developed sites in New Jersey.
View photos from our press conference about this exciting partnership. For more, see our FAQs about the Memorial Sloan Kettering – Hackensack Meridian Health Partnership.
